Millipore Sigma Vibrant Logo

MABF2194-25UL Anti-Dengue Virus 3/4 NS1 protein Antibody, clone 55

MABF2194-25UL
25 µL  
価格を検索中…
価格が見つかりません
Minimum Quantity needs to be mulitiple of
Maximum Quantity is
弊社照会 詳細を表示 
値引
()
 
弊社照会
現在国内在庫なし
現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

       

      お問合せください

      概要

      Replacement Information
      Description
      Catalogue NumberMABF2194-25UL
      DescriptionAnti-Dengue Virus 3/4 NS1 protein Antibody, clone 55
      Alternate Names
      • DENV 3 and 4 NS1 protein
      • Dengue virus 3/4 NS1 protein
      Background InformationDengue virus (DENV) is a mosquito-borne flavivirus and is one of the most common mosquito-transmitted viral infections. The DENV particle is about 500 nm in diameter and includes a positive-sense RNA genome with ~10,700 nucleotides and 3 structural proteins known as capsid (C), precursor membrane (prM), and envelope (E) proteins. In addition, the RNA genome of dengue virus also encodes seven nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5) that are shown to be essential for viral replication. DENV NS1, a 48-kDa glycoprotein (aa 776-1127 of genome polyprotein), is highly conserved among all flaviviruses and is essential for viral replication. It is expressed as a monomer in infected cells and after post-translational modification in the lumen of endoplasmic reticulum, it forms homodimers associated with organelle membranes and the cell membrane. NS1 is reported to be involved in immune evasion, pathogenesis, and viral replication. Once cleaved off the polyprotein, is targeted to three destinations: the viral replication cycle, the plasma membrane and the extracellular compartment. NS1 is secreted in a hexamer form, which is composed of three dimers with a detergent-sensitive hydrophobic central cavity and it plays a role against host immune response. NS1 is shown to induce expression of sialidases, heparanase, and activates cathepsin L, which activates heparinase via enzymatic cleavage. These effects are may contribute to the endothelial hyperpermeability commonly observed in severe dengue disease. During the recovery phase, NS1 is cleared from the circulation by antibody-mediated effects. Dengue virus 3 and 4 display about 85% sequence homology. Clone 55 detects NS1 protein in both DENV3 and 4. (Ref.: Chen, RU et al. (2018). J Biomed Sci. 25(1); 58; Bosch, I., et al. (2017). Sci. Transl. Med. 9(409); eaan1589).
      References
      Product Information
      FormatPurified
      PresentationPurified mouse monoclonal antibody IgG1 in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
      Applications
      ApplicationAnti-Dengue Virus 3/4 NS1 protein, clone 55, Cat. No. MABF2194, is a mouse monoclonal antibody that detects Dengue virus 3 and 4 NS1 protein and is tested for use in ELISA and Flow Cytometry.
      Key Applications
      • ELISA
      • Flow Cytometry
      Application NotesELISA Analysis: A representative lot detected Dengue Virus 3/4 NS1 protein in ELISA applications (Bosch, I., et. al. (2017). Sci Transl Med. 9(409); eaan1589).

      Flow Cytometry Analysis: A representative lot detected Dengue Virus 3/4 NS1 protein in Flow Cytometry applications (Bosch, I., et. al. (2017). Sci Transl Med. 9(409); eaan1589).
      Biological Information
      ImmunogenPurified recombinant Dengue virus NS1 protein expressed in mammalian cells.
      Clone55
      HostMouse
      SpecificityClone 55 (MA724.55) is a mouse monoclonal antibody that detects Dengue virus 3/4 NS1 protein. It targets an epitope within 16 amino acids from the wing-finger domain.
      IsotypeIgG1κ
      Species Reactivity
      • Virus
      Species Reactivity NoteVirus (dengue virus).
      Antibody TypeMonoclonal Antibody
      Purification MethodProtein G purified
      UniProt Number
      Molecular Weight~48 kDa calculated for NS1 protein; ~378.0 kDa for the entire genome polyprotein.
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by ELISA in DENV3 and DENV4 NS1 recombinant protein.

      ELISA Analysis: 5 µg/mL of this antibody detected recombinant NS1 protein from Dengue Virus 3/4.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
      Packaging Information
      Material Size25 µL
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      MABF2194-25UL 04061841588344

      Documentation

      Anti-Dengue Virus 3/4 NS1 protein Antibody, clone 55 (M)SDS

      タイトル

      英語版製品安全データシート((M)SDS) 

      Anti-Dengue Virus 3/4 NS1 protein Antibody, clone 55 試験成績書(CoA)

      タイトルロット番号
      Anti-Dengue Virus 3/4 NS1 protein, clone 55 - Q3418263 Q3418263

      参考資料

      参考資料の概要Pub Med ID
      Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum.
      Bosch, I; de Puig, H; Hiley, M; Carré-Camps, M; Perdomo-Celis, F; Narváez, CF; Salgado, DM; Senthoor, D; O'Grady, M; Phillips, E; Durbin, A; Fandos, D; Miyazaki, H; Yen, CW; Gélvez-Ramírez, M; Warke, RV; Ribeiro, LS; Teixeira, MM; Almeida, RP; Muñóz-Medina, JE; Ludert, JE; Nogueira, ML; Colombo, TE; Terzian, ACB; Bozza, PT; Calheiros, AS; Vieira, YR; Barbosa-Lima, G; Vizzoni, A; Cerbino-Neto, J; Bozza, FA; Souza, TML; Trugilho, MRO; de Filippis, AMB; de Sequeira, PC; Marques, ETA; Magalhaes, T; Díaz, FJ; Restrepo, BN; Marín, K; Mattar, S; Olson, D; Asturias, EJ; Lucera, M; Singla, M; Medigeshi, GR; de Bosch, N; Tam, J; Gómez-Márquez, J; Clavet, C; Villar, L; Hamad-Schifferli, K; Gehrke, L
      Sci Transl Med  9  N/A  2017

      概要を表示する
      28954927 28954927